Tiny Gem Archives - Page 5 of 68

WednesdayMay 20, 2026 10:00 am

Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer

University of North Carolina scientists have engineered immune cells that can destroy acute myeloid leukemia while sparing healthy blood tissue, overcoming a limitation that has plagued standard treatments, which have struggled to separate cancerous cells from normal cells. Immunologist Gianpietro Dotti and hematologist Paul Armistead directed research teams whose work appears in the journal Blood, offering an approach that may expand options for patients battling this deadly disease. Acute myeloid leukemia afflicts adults and children alike, with diagnoses rising steadily, particularly across America and countries experiencing population aging. The malignancy typically advances rapidly through the bone marrow and bloodstream once it develops. Unfortunately, existing therapies damage normal blood-forming…

MondayMay 18, 2026 10:00 am

Why China Is Unlikely to Use More Coal Even as Iran War Rages

Fighting in Iran has sent oil above $100 a barrel, roughly doubled LNG prices across Asia, and pushed coal higher too. When oil and gas grow costly, coal starts to look like the cheaper alternative, and the conventional wisdom holds that consumption will follow. In China, however, the way its coal market is structured means that outcome is far less certain than it looks. Coal generates around 60% of China’s electricity and accounts for over 95% of all carbon emissions produced by the power sector. Steel production, which produces 15–17% of national emissions, also depends heavily on coal. Despite the country’s continued reliance on coal-fired energy, current conditions in…

FridayMay 15, 2026 10:30 am

Frontieras North America Inc.’s Game-Changing Tech ‘Unlocks’ Coal as Multi-Output Industrial Feedstock

The company’s proprietary FASForm(TM) platform advancing new approach to coal. Frontieras processes coal into multiple commercially valuable outputs, tied to markets estimated at more than $2 trillion. Core thesis is that coal’s largest missed opportunity lies not in power generation alone but in its unrealized value as a diversified industrial resource. Global demand for energy is accelerating at a historic pace as artificial intelligence (“AI”), advanced manufacturing and industrial expansion place increasing pressure on existing power systems. Governments and industries are exploring nearly every available energy source to meet that demand, yet one of the world’s most abundant and energy-dense…

WednesdayMay 13, 2026 10:00 am

Pentagon Seeks to Mitigate Quantum Computing Risks to the F-35

The Pentagon is taking steps toshield the F-35's encryption systems from the growing threat posed by quantum computing. A contract notice published May 6, 2026, by the F-35 Joint Program Office signals the shift to quantum computing-proof encryption. The military is moving to future-proof one of the jet's core security systems before quantum computing advances enough to break current encryption. Known as the In-Line File Encryption Device, the component at the center of this work is a specialized security chip embedded in the aircraft. Its job is to check that every piece of software on the jet is genuine and…

MondayMay 11, 2026 9:05 am

Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes

A systematic review in JAMA Network Open suggests earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes in patients being treated for late-stage solid tumors. The analysis pooled data from 29 studies encompassing more than 6,000 patients. Earlier timing was linked to gains in both survival endpoints, though prospective validation is required before scheduling adjustments can be broadly adopted. The studies covered tumor types like melanoma, gastric, renal cell, esophageal, small cell lung, urothelial, biliary tract, and hepatocellular carcinoma. Twenty-seven of the 29 were retrospective cohorts. The other two comprised a randomized trial in non-small cell lung cancer and a prospective cohort study in head and neck squamous cell carcinoma. The breadth of coverage reflects growing interest in whether treatment timing, not…

ThursdayMay 07, 2026 9:00 am

Frontieras North America’s Transformative Technology Reimagines Coal for the Future

Coal remains the largest source of electricity generation in the world. At the heart of Frontieras’s FASForm technology is a continuous solid carbon fractionation process that thermally cracks coal in a reducing atmosphere. Beyond fuels and hydrogen, the FASForm process enables the creation of additional valuable industrial chemicals and materials. Global energy systems are under increasing strain as industrial demand accelerates and reliable baseload power becomes more critical to economic stability. Frontieras North America is developing a breakthrough energy-processing technology known as FASForm(TM) that deconstructs coal and other solid hydrocarbons into multiple high-value fuels and industrial products, redefining the utility and economics of coal…

WednesdayMay 06, 2026 10:00 am

Blocking Fructose Metabolism Boosts Immune Response to Childhood Cancer

Researchers at Johns Hopkins may have found a new approach to group 3 medulloblastoma, a deadly and hard-to-treat pediatric brain cancer. Mouse experiments suggest that disrupting how tumor cells generate energy can slow the disease. The research was conducted at the Kimmel Cancer Center and published in Acta Neuropathologica Communications. Group 3 medulloblastoma is one of the most difficult pediatric brain cancers to treat, and effective therapies remain scarce. The new research reveals how tumor cells rewire their energy production to fuel rapid growth. It also shows that interfering with those processes can slow the disease. Senior author Ranjan Perera, Ph.D., of Johns Hopkins All Children's Hospital, said the work points toward a largely unexplored therapeutic avenue. According…

MondayMay 04, 2026 10:00 am

Study Finds That Vitamin D Supercharges Chemotherapy Against Breast Cancer

A clinical trial in Brazil has found that adding a daily vitamin D supplement to standard chemotherapy improved outcomes for women with breast cancer. The finding contributes to growing interest in low-cost nutritional approaches that could enhance cancer treatment. Unlike many pharmaceutical agents designed to boost chemotherapy response, such an intervention would be widely accessible and inexpensive. The implications extend to any clinical setting seeking affordable ways to improve treatment response in breast cancer. Conducted at the oncology clinic of FMB-UNESP, São Paulo State University's medical school, the trial enrolled 80 women over the age of 45. Participants were split into equal cohorts, one…

WednesdayApr 29, 2026 10:00 am

3 Breakthroughs Showing Quantum Computing is Closer Than Initially Thought

Quantum computing has long been described as a technology perpetually a decade away from practical relevance. However, recent advancements in the technology may bring quantum computing to bear sooner than projected. Three areas of recent progress tell that story: hardware stability, real-world problem-solving, and the resource requirements for error correction. In each, results have arrived sooner than most of the research community predicted. For starters, continued research into quantum computing has made the technology more stable over time. Qubits are the computing units of quantum machines, capable of representing multiple states simultaneously rather than being limited to a binary value. That capability enables computations classical systems cannot match, but qubits are highly sensitive to interference and can…

MondayApr 27, 2026 10:00 am

New Molecule May Open New Therapeutic Pathway Against Brain Cancer

Researchers at Brown University Health have identified a molecule that could potentially alter how glioblastoma responds to treatment. Glioblastoma is the deadliest and most prevalent form of brain cancer affecting adults, with a five-year survival rate of just 5%-10%. The molecule, designated miR-181d, is a type of microRNA that appears to work through two separate biological mechanisms. Early findings suggest it could open treatment to patients currently beyond the reach of existing therapies. Brown University Health's study began with an unusual patient group: individuals who survive the disease far longer than their prognosis would predict. The team analyzed hundreds of…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Category: Tiny Gem